News

Researchers show new therapeutic avenues in bone repair

Birmingham researchers have shown PEPITEM, a naturally occurring peptide (small protein) holds promise as a new therapeutic for osteoporosis and other disorders that feature...

HI-Bio acquired by Biogen in $1.8bn deal

Biogen is set to acquire Jeito Capital company HI-Bio, a clinical-stage portfolio biotechnology company focused on targeted therapies for patients with severe immune-mediated diseases...

Zai Lab and Innoviva Specialty Therapeutics secure approval for XACDURO for hospital-acquired and ventilator-associated...

China’s National Medical Products Administration (NMPA) has approved Zai Lab’s New Drug Application (NDA) for XACDURO® (sulbactam-durlobactam) for the treatment of hospital-acquired bacterial pneumonia...